Factors involved in gastrointestinal bleeding in advanced cancer patients followed at home

Supportive Care in Cancer

Volumn 12, Issue 2, 2004, Pages 95-98

  Mercadante, Sebastiano ^a   Fusco, Flavio ^b   Valle, Alessandro ^c   Fulfaro, Fabio ^d   Casuccio, Alessandra ^d   Silvestro, Stefania ^b   Donelli, Emanuela ^b  

^a LA MADDALENA CANCER CENTER   (Italy)

^b ASL 3   (Italy)

^c Hospice FARO   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cancer; Complications; Gastrointestinal bleeding; Multicenter epidemiologic study; NSAIDs; Steroids

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADVANCED CANCER; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER PALLIATIVE THERAPY; CANCER PATIENT; DUODENUM ULCER; GASTROINTESTINAL HEMORRHAGE; HOME CARE; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MORTALITY; PALLIATIVE THERAPY; PRIORITY JOURNAL; RISK FACTOR; STOMACH PROTECTION; STOMACH ULCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HOME CARE SERVICES; HUMANS; LONGITUDINAL STUDIES; MALE; NEOPLASMS; PALLIATIVE CARE; PROSPECTIVE STUDIES; RISK FACTORS; STEROIDS;

EID: 1242269338     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-003-0519-8     Document Type: Article

References (12)

1. Mercadante S, Barresi L, Casuccio A, Fulfaro F (2000) Gastrointestinal bleeding in advanced cancer patients. J Pain Symptom Manage 19:160-162
2. Tramèr MR, Moore RA, Reynolds JM, McQuay HJ (2000) Quantitative estimation of rare events high follow a biological progression: a new model applied to chronic NSAID use. Pain 85:169-182
3. Hansen JM, Hallas J, Lauritsen JM, Bytzer P (1996) Non-steroidal antiinflammatory drugs and ulcer complications: a risk factor analysis for clinical decision making. Scand J Gastroenterol 31:126-130
4. Hallas J, Lauritsen J, Villadsen HD, Gram LF (1995) Nonsteroidal antiinflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates. Scand J Gastroenterol 30:438-444
5. McMahon AD, Evans JM, White G, Murray FE, McGilchrist MM, McDevitt DG, MacDonald TM (1997) A cohort study (with re-sampled comparator groups) to measure the association between new NSAID prescribing and upper gastrointestinal hemorrhage and perforation. J Clin Epidemiol 50:351-356
6. Schug SA, Zech D, Grond S, Jung H, Meuser T, Stobbe B (1992) A long term survey of morphine in cancer pain patients. J Pain Symptom Manage 7:259-266
7. Mercadante S (1999) Treatment and outcome of cancer pain in advanced cancer patients followed at home. Cancer 85:1849-1858
8. Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA (1995) Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 63:65-76
9. Laszlo A, Kelly JP, Kaufman DE, Sheehan JE, Retsagi G, Wiholm BE, Koff RS, Sundstrom A, Shapiro S (1998) Clinical aspects of upper gastrointestinal bleeding associated with the use of nonsteroidal antiinflammatory drugs. Am J Gatsroenterol 93:721-725
10. Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF (1996) Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med 156:1530-1536
11. Ellershaw JE (1994) Corticosteroids and peptic ulceration. Palliat Med 8:313-319
12. Schell HW (1972) Adrenal corticosteroid therapy in far advanced cancer. Geriatrics 27:131-141.